Skip to content

Clinical trials

Phase 2 Mental Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 2 Clear all

122 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20051
20062
20073
20083
20092
20102
20117
20123
20135
20146
20152
20161
20173
20188
20194
20204
20219
202213
20237
20246
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Recruiting13
Unknown status9
Terminated9
Withdrawn4
Not yet recruiting3
Active, not recruiting3
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)8
Brigham and Women's Hospital4
MapLight Therapeutics4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AbbVie3
Alkahest, Inc.3
HB BioTech, LLC3
Inmune Bio, Inc.3
Novartis Pharmaceuticals3
University of California, San Diego3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders122
Schizophrenia26
Nervous System Diseases24
Brain Diseases22
Dementia22
Central Nervous System Diseases20
Mood Disorders18
Psychotic Disorders17
Neurologic Manifestations16
Alzheimer Disease15

Trials

Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.

22 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.